PODD Insider Trading

Insider Ownership Percentage: 0.47%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,860,673.63

Insulet Insider Trading History Chart

This chart shows the insider buying and selling history at Insulet by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$3.97MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Insulet Share Price & Price History

Current Price: $258.75
Price Change: Price Decrease of -1.52 (-0.58%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for PODD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$258.75Closing price on 03/28/25:

SEC Filings (Institutional Ownership Changes) for Insulet (NASDAQ:PODD)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PODD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$983Mbought$4.32BsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20B$0$20BTotal InflowsTotal Outflows
Insulet logo
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Read More on Insulet

Today's Range

Now: $258.75
Low: $255.76
High: $261.60

50 Day Range

MA: $271.69
Low: $237.06
High: $288.29

52 Week Range

Now: $258.75
Low: $160.19
High: $289.46

Volume

536,841 shs

Average Volume

706,989 shs

Market Capitalization

$18.17 billion

P/E Ratio

44.69

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Insulet?

Insulet's top insider investors include:
  1. Shacey Petrovic (Director)
  2. Timothy J Scannell (Director)
  3. James Hollingshead (CEO)
  4. Wayde D Mcmillan (CFO)
  5. Mark N Field (SVP)
  6. Eric Benjamin (EVP)
  7. Lauren Budden (CAO)
  8. Dan Manea (SVP)
  9. Prem Singh (SVP)
  10. Wayne AI Frederick (Director)
  11. Luciana Borio (Director)
Learn More about top insider investors at Insulet.

Who are the major institutional investors of Insulet?

Insulet's top institutional investors include:
  1. Vanguard Group Inc. — 12.10%
  2. Capital Research Global Investors — 10.62%
  3. Baillie Gifford & Co. — 3.36%
  4. Geode Capital Management LLC — 2.54%
  5. FIL Ltd — 2.04%
  6. Clearbridge Investments LLC — 2.00%
Learn More about top institutional investors of Insulet stock.

Which institutional investors are selling Insulet stock?

Within the previous quarter, PODD stock was sold by these institutional investors:
  1. Schroder Investment Management Group
  2. New York State Common Retirement Fund
  3. BNP Paribas Financial Markets
  4. Capital Research Global Investors
  5. Legal & General Group Plc
  6. William Blair Investment Management LLC
  7. First Light Asset Management LLC
  8. Adage Capital Partners GP L.L.C.
During the previous year, company insiders that have sold Insulet company stock include:
  1. Shacey Petrovic (Director)
  2. Timothy J Scannell (Director)
  3. James Hollingshead (CEO)
  4. Wayde D Mcmillan (CFO)
  5. Mark N Field (SVP)
Learn More investors selling Insulet stock.

Which institutional investors are buying Insulet stock?

Within the last quarter, PODD stock was purchased by institutional investors including:
  1. Norges Bank
  2. Raymond James Financial Inc.
  3. Alecta Tjanstepension Omsesidigt
  4. Artisan Partners Limited Partnership
  5. Northern Trust Corp
  6. Universal Beteiligungs und Servicegesellschaft mbH
  7. Marshall Wace LLP
  8. Proficio Capital Partners LLC
Within the last year, these company insiders have bought Insulet stock:
  1. Shacey Petrovic (Director)
  2. Timothy J Scannell (Director)
Learn More investors buying Insulet stock.